The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 67 of the 70 references it cites were found in a registry or an index; 24 of the 66 sources its claims cite were checked for support.
Abstract
Background: Self-monitoring of blood glucose (SMBG) is considered of little clinical benefit for adults with non-insulin-treated type 2 diabetes, but no comprehensive review of a structured approach to SMBG has been published to date. Purpose: To conduct a systematic review and meta-analysis of the impact of sSMBG on HbA1c, treatment modifications, behavioral and psychosocial outcomes, and; examine the moderating effects of sSMBG protocol characteristics on HbA1c. Data sources: Four databases searched (November 2020; updated: February 2022). Study selection: Inclusion criteria: non-randomized and randomized controlled trials (RCTs) and prospective observational studies; reporting effect of sSMBG on stated outcomes; among adults (≥18 years) with non-insulin-treated type 2 diabetes. Studies excluded if involving children or people with insulin-treated or other forms of diabetes. Data extraction and analysis: Outcome data extracted, and risk of bias/quality assessed independently by two researchers. Meta-analysis was conducted for RCTs, and moderators explored (HbA1c only). Data synthesis: From 2,078 abstracts, k=23 studies were included (N=5,372). Risk of bias was evident and study quality was low. Outcomes assessed included: HbA1c (k=23), treatment modification (k=16), psychosocial/behavioral outcomes (k=12). Meta-analysis revealed a significant mean difference favoring sSMBG in HbA1c (-0·29%, 95% CI: -0·46 to -0·11, k=13) and diabetes self-efficacy (0.17%, 95% CI: 0.01 to 0.33, k=2). Meta-analysis revealed no significant moderating effects by protocol characteristics. Limitations: Findings limited by heterogeneity in study designs, intervention characteristics, and psychosocial assessments. Conclusion: A small positive effect of sSMBG on HbA1c and diabetes self-efficacy was observed. Narrative synthesis of sSMBG intervention characteristics may guide future implementation. PROSPERO registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020208857, identifier CRD42020208857.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis found that structured self-monitoring of blood glucose (sSMBG) in adults with non-insulin-treated type 2 diabetes produced a small but statistically significant improvement in HbA1c and diabetes self-efficacy compared with usual care. Evidence for treatment modification, behavioral, and other psychosocial outcomes was limited and heterogeneous.
Key findings
- From 2,078 abstracts, 23 studies were included (N=5,372); all assessed HbA1c, 16 reported treatment modification, and 12 reported behavioral or psychosocial outcomes.
- Meta-analysis of 13 RCTs found a significant between-group mean difference in HbA1c favoring sSMBG: –0.28% (95% CI: –0.46 to –0.11) in the results, reported as –0.29% (95% CI: –0.46 to –0.11) in the abstract.
- Meta-analysis found a significant improvement in diabetes-specific self-efficacy (k=2; 0.17, 95% CI: 0.01 to 0.33), but no significant effects for general emotional well-being, depressive symptoms, diabetes distress, or diabetes treatment satisfaction.
- No significant moderating effects of sSMBG protocol characteristics on HbA1c were found; narrative synthesis suggested effective interventions often used at least four checks per day, tracking of additional data, interpretation training, and health professional feedback/action.
Methods
- Systematic review and meta-analysis of RCTs, non-randomized trials, and prospective observational studies; four databases were searched in November 2020 and updated in February 2022.
- Inclusion criteria were adults (≥18 years) with non-insulin-treated type 2 diabetes; sSMBG was defined as SMBG conducted in a purposeful, pre-specified pattern over a pre-specified timeframe, involving at least paired monitoring.
- Random-effects meta-analysis was conducted for RCTs comparing sSMBG with usual care (no SMBG or unstructured SMBG), using restricted maximum likelihood estimation in the metafor package; moderators were explored for HbA1c only, and risk of bias/quality was assessed with Cochrane and NHLBI tools.
Limitations
- Stated: findings were limited by heterogeneity in study designs, intervention characteristics, and psychosocial assessments; few studies reported outcomes beyond HbA1c, and those that did used inconsistent operationalization.
- Stated: reliability may be limited by heterogeneous sSMBG interventions, variation in control conditions, risk of bias/quality, and inclusion of non-RCT designs; one RCT was excluded from meta-analysis as a comparative effectiveness trial, which may have affected the overall effect size.
- Stated: the review could not examine overall time effects or predictors of sustained effect, did not assess differential impact by baseline HbA1c, excluded non-English studies, and did not examine cost-effectiveness, outcomes beyond HbA1c, or qualitative research. Evident from the text: the self-efficacy meta-analysis drew on only two RCTs, including one reporting per-protocol results only.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
16 Valid · 3 Not valid · 28 Not checked · 56 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“However, inclusion criteria specified randomized controlled trials (RCTs) including a uSMBG comparator (k=3 (29) and k=4 (30)), thus overlooking evidence where sSMBG was compared to usual care, no SMBG, or CGM.”
§ The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis > Introduction
What the sources say
- Disputedcites [29] Mannucci, 2018, Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated type 2 diabetes: a meta-analysis of randomized controlled trials, J. Diabetes Sci. Technol. sourceExperimental — accuracy not yet measured
Study Selection (p. 2) says this meta-analysis included RCTs comparing SMBG with no SMBG, as well as trials comparing structured with unstructured SMBG. Retrieved Trials (p. 3) reports eight trials with a no-SMBG comparator, contrary to the claim that its criteria required an unstructured-SMBG comparator and overlooked no-SMBG evidence. (LLM, conf=0.93)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [30] Chircop, 2021, Systematic review of self-monitoring of blood glucose in patients with type 2 diabetes, Nurs. Res. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Furthermore, previous reviews have paid little attention to the impact of sSMBG on treatment modification, behavioral outcomes (i.e. self-care) or psychosocial outcomes (e.g. self-efficacy, treatment satisfaction, well-being, quality of life) (17, 29, 31).”
§ The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis > Introduction
What the sources say
- Disputedcites [17] Malanda, 2012, Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin, Cochrane Database Syst. Rev. sourceExperimental — accuracy not yet measured
The review directly contradicts the claim about psychosocial outcomes: its “Types of outcome measures” section lists quality of life, well-being, and patient satisfaction as primary outcomes, and its “Clinical relevance of findings” section says the authors paid attention to them. The review does not establish the broader claim that previous reviews paid little attention to treatment modification or self-care. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [29] Mannucci, 2018, Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated type 2 diabetes: a meta-analysis of randomized controlled trials, J. Diabetes Sci. Technol. sourceExperimental — accuracy not yet measured
The introduction (p. 2) says previous meta-analyses did not properly account for the SMBG regimen or the use of glucose data to adjust medications, supporting the treatment-modification portion. It does not say previous reviews paid little attention to self-care outcomes; it also notes (p. 1) that a Cochrane review assessed evidence on satisfaction, well-being, and quality of life. (LLM, conf=0.85)
- Could not verifycites [31] Zhu, 2016, Is self-monitoring of blood glucose effective in improving glycaemic control in type 2 diabetes without insulin treatment: a meta-analysis of randomised controlled trials, BMJ Open sourceExperimental — accuracy not yet measured
The Introduction and Discussion compare previous reviews chiefly on glycaemic control and clinical indices. The Results > Overall effects lists the outcomes this meta-analysis assessed, but no passage says previous reviews paid little attention to treatment modification, self-care, or psychosocial outcomes. Searches for those outcomes and for the claimed gap in previous reviews found no supporting passage; page numbers were unavailable in our copy. (LLM, conf=0.74)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“The DiGEM study identified a small, significant between-group difference in health status (EQ-5D) (20).”
§ The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis > Results > Psychosocial and behavioral outcomes
What the sources say
- Supportedcites [20] Simon, 2008, Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial, BMJ source
The Effects section reports a significant between-group difference in EQ-5D-derived quality of life: the more intensive self-monitoring group scored 0.072 lower than the usual-care group (95% CI −0.127 to −0.017). The claim does not specify which groups differed, but its description of a small, significant difference matches this result. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Importantly, a key gap in the sSMBG evidence is investigation of participants’ experiences of and/or satisfaction with glucose monitoring, which was assessed only by Cox et al. (49)”
§ The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis > Discussion
What the sources say
- Partly supportedcites [49] Cox, 2020, Glycemic excursion minimization in the management of type 2 diabetes: a novel intervention tested in a randomized clinical trial, BMJ Open Diabetes Res. Care sourceExperimental — accuracy not yet measured
The Methods (Procedures; page not provided) say participants completed questionnaires about attitudes toward glucose monitoring, and the Results (Primary outcome variable; page not provided) report glucose-monitoring satisfaction scores. This establishes that Cox et al. assessed satisfaction, but this paper cannot establish that it was the only study in the sSMBG evidence to do so. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The latter is consistent with the findings of two prior meta-analyses, which identified greater clinical benefit when SMBG was followed by responsive treatment modifications (29, 30).”
§ The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis > Discussion
What the sources say
- Supportedcites [29] Mannucci, 2018, Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated type 2 diabetes: a meta-analysis of randomized controlled trials, J. Diabetes Sci. Technol. source
This source is a meta-analysis, and its Results (p. 3) report a greater HbA1c reduction in trials where physicians used SMBG data to adjust diabetes medications than in trials without consistent SMBG-based adjustments. The finding concerns patients with non-insulin-treated type 2 diabetes and supports this source's contribution to the citing sentence; it does not establish what the other cited meta-analysis found. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [30] Chircop, 2021, Systematic review of self-monitoring of blood glucose in patients with type 2 diabetes, Nurs. Res. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
55 more claims · 4 with their cited sources checked
Create a free account to see all 103 claims and to verify the 2 references still open.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 26
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“oral diabetes medication changes (0.44, 95% CI: -0.12 to 0.10)”
§ The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis > Results > Healthcare professionals’ prescriptions of diabetes medications
Reported 0.44 · recomputed -0.01
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis > Methods > Data extraction and analysis
“Meta-analyses were performed only where heterogeneity was <85%.”
§ The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis > Results > Psychosocial and behavioral outcomes
“| Diabetes distress | 2 (54, 62) | 591 | 152.05 (1) | 99.34% | <0.001 | -0.91 (-3.66 to 1.85) | 0.52 |”
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464 · cited 1×
“no SMBG or uSMBG), a random-effects metaanalysis (using a restricted maximum likelihood estimation method in the metafor package for R (38), version 3.”
MethodCochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Page, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n160 · Cited by 13,262
Cumpston, M., Li, T., Page, M. J., Chandler, J., Welch, V. A., Higgins, J. P., & Thomas, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000142 · Cited by 7,218
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s006 · Cited by 847
Nicolucci, A., Kovacs Burns, K., Holt, R. I. G., Comaschi, M., Hermanns, N., Ishii, H., Kokoszka, A., Pouwer, F., Skovlund, S. E., Stuckey, H., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12245 · Cited by 739
Clinical Inertia in People With Type 2 Diabetes
Khunti, K., Wolden, M. L., Thorsted, B. L., Andersen, M., & Davies, M. J. (2013) · Diabetes Care · doi:10.2337/dc13-0331 · Cited by 613 · cited 1×
“However, there is evidence demonstrating sub-optimal diabetes management, including diet and physical activity (3, 4), inconsistent and nonpersistent use of prescribed diabetes medications (5); and routine delay of clinically-indicated treatment intensification, including insulin (6, 7).”
BackgroundBuse, J. B., Wexler, D. J., Tsapas, A., Rossing, P., Mingrone, G., Mathieu, C., D’Alessio, D. A., & Davies, M. J. (2020) · Diabetologia · doi:10.1007/s00125-019-05039-w · Cited by 487
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc10-1732 · Cited by 429
Farmer, A., Wade, A., Goyder, E., Yudkin, P., French, D., Craven, A., Holman, R., Kinmonth, A.-L., & Neil, A. (2007) · BMJ · doi:10.1136/bmj.39247.447431.be · Cited by 407 · cited 1×
“DiGEM (51) includes two treatment arms relative to control referred to as Farmer 2007 T1 and T2.”
BackgroundKhunti, K., Gomes, M. B., Pocock, S., Shestakova, M. V., Pintat, S., Fenici, P., Hammar, N., & Medina, J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13088 · Cited by 367
Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading
Radin, M. S. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2595-x · Cited by 361
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
Malanda, U. L., Welschen, L. M., Riphagen, I. I., Dekker, J. M., Nijpels, G., & Bot, S. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005060.pub3 · Cited by 358
Nalysnyk, L., Hernandez‐Medina, M., & Krishnarajah, G. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01160.x · Cited by 343
Heisler, M., Piette, J. D., Spencer, M., Kieffer, E., & Vijan, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.816 · Cited by 326
Meal-Related Structured Self-Monitoring of Blood Glucose
Schwedes, U., Siebolds, M., Mertes, G., & For the SMBG Study Group (2002) · Diabetes Care · doi:10.2337/diacare.25.11.1928 · Cited by 300
Self-monitoring of blood glucose in type 2 diabetes: systematic review
Clar, C., Barnard, K., Cummins, E., Royle, P., & Waugh, N. (2010) · Health Technology Assessment · doi:10.3310/hta14120 · Cited by 274
Simon, J., Gray, A., Clarke, P., Wade, A., Neil, A., & Farmer, A. (2008) · BMJ · doi:10.1136/bmj.39526.674873.be · Cited by 206
Peel, E., Douglas, M., & Lawton, J. (2007) · BMJ · doi:10.1136/bmj.39302.444572.de · Cited by 203
Davidson, M. B., Castellanos, M., Kain, D., & Duran, P. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.006 · Cited by 178
DURÁN, A., MARTÍN, P., RUNKLE, I., PÉREZ, N., ABAD, R., FERNÁNDEZ, M., DEL VALLE, L., SANZ, M. F., & CALLE‐PASCUAL, A. L. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00081.x · Cited by 156
Franciosi, M., Lucisano, G., Pellegrini, F., Cantarello, A., Consoli, A., Cucco, L., Ghidelli, R., Sartore, G., Sciangula, L., Nicolucci, A., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03268.x · Cited by 137
Greenwood, D. A., Blozis, S. A., Young, H. M., Nesbitt, T. S., & Quinn, C. C. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4112 · Cited by 128
Allemann, S., Houriet, C., Diem, P., & Stettler, C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903364665 · Cited by 115
Barnett, A. H., Krentz, A. J., Strojek, K., Sieradzki, J., Azizi, F., Embong, M., Imamoglu, S., Perušičová, J., Uličiansky, V., & Winkler, G. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00894.x · Cited by 106 · cited 1×
“DINAMIC 1 Barnett (2008) (52) 5 (7/mth) 2 (+1/mth) 27/27 – – – – NR NR”
Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring
Jackson, M. A., Ahmann, A., & Shah, V. N. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0007 · Cited by 106 · cited 1×
“required to identify glucose trends), but there remains limited evidence for the impact or acceptability of CGM among people with non-insulin-treated type 2 diabetes (27) and recommendations for its use among people with type 2 diabetes are limited to those administering insulin (28).”
BackgroundBosi, E., Scavini, M., Ceriello, A., Cucinotta, D., Tiengo, A., Marino, R., Bonizzoni, E., Giorgino, F., & on behalf of the PRISMA Study Group (2013) · Diabetes Care · doi:10.2337/dc13-0092 · Cited by 105
Mannucci, E., Antenore, A., Giorgino, F., & Scavini, M. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817719290 · Cited by 90
Bergenstal, R. M., Mullen, D. M., Strock, E., Johnson, M. L., & Xi, M. X. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108106 · Cited by 87 · cited 10×
“In addition, the reliability of the findings may be limited by the heterogeneity of eligible sSMBG interventions (including disparate use of HbA1c and/or sSMBG to inform clinical management), variation in control conditions (i.e. CGM, non-SMBG, sSMBG, uSMBG)), the risk of bias/quality of these, and the inclusion of no…”
ResultInfluentialPolonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Axel-Schweitzer, M., Petersen, B., & Wagner, R. S. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0073 · Cited by 85
Zhu, H., Zhu, Y., & Leung, S.-W. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010524 · Cited by 84
Jones, A., Vallis, M., & Pouwer, F. (2015) · Diabetic Medicine · doi:10.1111/dme.12620 · Cited by 79
Kempf, K., Kruse, J., & Martin, S. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0008 · Cited by 66
Beard, E., Clark, M., Hurel, S., & Cooke, D. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2009.11.008 · Cited by 61
Siebolds, M., Gaedeke, O., & Schwedes, U. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2005.06.013 · Cited by 59 · cited 3×
“SMBG, Schwedes (2002), Siebolds (2006) (36, 37) 6 2 26/26 Yes Yes Yes Yes ≥70% of the required checks NR”
BackgroundBonomo, K., De Salve, A., Fiora, E., Mularoni, E., Massucco, P., Poy, P., Pomero, A., Cavalot, F., Anfossi, G., & Trovati, M. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.021 · Cited by 53
French, D. P., Wade, A. N., Yudkin, P., Neil, H. A. W., Kinmonth, A. L., & Farmer, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02569.x · Cited by 49
Kempf, K., Kruse, J., & Martin, S. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0116 · Cited by 48
Fisher, L., Polonsky, W., Parkin, C. G., Jelsovsky, Z., Amstutz, L., & Wagner, R. S. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.619176 · Cited by 47 · cited 4×
“General emotional well-being 4* (37, 51, 62, 63) 1,198 5.”
BackgroundResultInfluentialFisher, L., Polonsky, W. H., Parkin, C. G., Jelsovsky, Z., Petersen, B., & Wagner, R. S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.016 · Cited by 44 · cited 2×
“In contrast, per protocol analysis of the STeP study showed a significant between-group difference, favoring sSMBG, for general emotional well-being (WHO-5), regimen-related diabetes distress (DDS subscale), and diabetes-specific self-efficacy (CIDS) (61, 62, 64).”
BackgroundResultSelf-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC).
Kleefstra, N., Hortensius, J., Logtenberg, S. J. J., Slingerland, R. J., Groenier, K. H., Houweling, S. T., Gans, R. O. B., van Ballegooie, E., & Bilo, H. J. G. (2010) · PubMed · Cited by 41
Kempf, K., Tankova, T., & Martin, S. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0213 · Cited by 40
Parsons, S. N., Luzio, S. D., Harvey, J. N., Bain, S. C., Cheung, W. Y., Watkins, A., & Owens, D. R. (2019) · Diabetic Medicine · doi:10.1111/dme.13899 · Cited by 39
Self-monitoring of blood glucose in non-insulin treated type 2 diabetes
Liu, X. (2009) · Intern J Endocrinol Metab · doi:10.3760/cma.j.issn.1673-4157.2009.06.022 · Cited by 35
Systematic review of self-monitoring of blood glucose in patients with type 2 diabetes
Chircop, J., Sheffield, D., & Kotera, Y. (2021) · Nursing Research · doi:10.1097/nnr.0000000000000542 · Cited by 34 · cited 6×
“They identified greater improvement in HbA1c associated with sSMBG (29, 30), particularly when monitoring data informed medication adjustments (29).”
BackgroundResultInfluentialGarcía de la Torre, N., Durán, A., del Valle, L., Fuentes, M., Barca, I., Martín, P., Montañez, C., Perez-Ferre, N., Abad, R., Sanz, F., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0467-9 · Cited by 24
Russo, G. T., Scavini, M., Acmet, E., Bonizzoni, E., Bosi, E., Giorgino, F., Tiengo, A., Cucinotta, D., & on behalf of the PRISMA Study Group (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0358 · Cited by 21
Speight, J., Browne, J. L., & Furler, J. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761957 · Cited by 20
Self-citationHalliday, J. A., Hendrieckx, C., Beeney, L., & Speight, J. (2015) · Diabetic Medicine · doi:10.1111/dme.12768 · Cited by 20
Self-citationCox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., Holmes, V., Green Pastors, J., Wolf, A., Fang, K., & McCall, A. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001795 · Cited by 20
Nishimura, A., Harashima, S.-I., Fujita, Y., Tanaka, D., Wang, Y., Liu, Y., & Inagaki, N. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.08.019 · Cited by 18
Winkley, K., Upsher, R. J., Polonsky, W. H., & Holmes‐Truscott, E. (2019) · Diabetic Medicine · doi:10.1111/dme.14214 · Cited by 18 · cited 1×
“However, there is evidence demonstrating sub-optimal diabetes management, including diet and physical activity (3, 4), inconsistent and nonpersistent use of prescribed diabetes medications (5); and routine delay of clinically-indicated treatment intensification, including insulin (6, 7).”
BackgroundSelf-citationKan, K., Zhu, W., Lu, F., Shen, Y., Gao, F., Mo, Y., He, X., Bao, Y., Zhou, J., & Jia, W. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0275 · Cited by 16
B. Davidson, M. (2010) · Reviews on Recent Clinical Trials · doi:10.2174/157488710792007248 · Cited by 15
Austin, M. M. (2013) · Diabetes Spectrum · doi:10.2337/diaspect.26.2.83 · Cited by 15
Testing times! Choosing Wisely when it comes to monitoring type 2 diabetes
Speight, J., Browne, J. L., & Furler, J. S. (2015) · Medical Journal of Australia · doi:10.5694/mja15.00639 · Cited by 12 · cited 3×
“Such targeted use of sSMBG may be both clinically- and cost-effective (21, 29, 30).”
BackgroundSelf-citationMalanda, U. L., Bot, S. D. M., Kostense, P. J., Snoek, F. J., Dekker, J. M., & Nijpels, G. (2016) · Diabetic Medicine · doi:10.1111/dme.12849 · Cited by 12
Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes?
Beck, R. W., & Bergenstal, R. M. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0374 · Cited by 12
Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
Kleefstra, N., Hortensius, J., van Hateren, K. J., Logtenberg, S. J., Houweling, S. T., Gans, R. O., & Bilo, H. J. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s4580 · Cited by 11
Madeo, B., Diazzi, C., Granata, A. R. M., Ghoch, M. E., Greco, C., Romano, S., Scaltriti, S., & Rochira, V. (2020) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.15586/jptcp.v27isp2.680 · Cited by 9
Cander, S., Gül, Ö. Ö., Gül, C. B., Yavaş, S., & Ersoy, C. (2015) · Endocrinology research and practice. · doi:10.4274/tjem.2748 · Cited by 3 · cited 3×
“In the two prospective observational studies, small significant reductions were observed in HbA1c from baseline to study end (33, 34, 43).”
BackgroundComparison of different models of structured self-monitoring of blood glucose in type 2 diabetes
Li, C.-L., Wu, Y.-C., Kornelius, E., Chen, Y.-J., Lin, Y.-T., Hsiao, H.-W., Peng, C.-H., Yang, Y.-S., & Huang, C.-N. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0082 · Cited by 2 · cited 4×
“(35) reported significantly greater improvement in general emotional well-being (WHO-5) and reduction in diabetes distress (PAID) among participants performing monthly seven-point profiles, or paired monitoring three days per week, relative to those performing more frequent paired monitoring (six days per week).”
BackgroundInfluentialNgaosuwan, K., & Osataphan, S. A. (2015) · PubMed · Cited by 2
Research works printed but not linked: 2
- Ventura, 2016, Diabetes MILES-2 2016 survey report
- 2020, Management of type 2 diabetes: a handbook for general practice
Cited by
7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 280
Grady, M., Holt, E., Cameron, H., & Edelman, S. V. (2025) · Scientific Reports · doi:10.1038/s41598-025-93605-1 · Cited by 4
Toletti, G., Boaretto, A., Loreto, C. D., et al. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2024.1328181 · Cited by 1
Ma, X., Chattopadhyay, K., Xu, M., Li, L., & Li, J. (2025) · JMIR mhealth and uhealth · doi:10.2196/65919 · Cited by 2
Foo, N., Chodapaneedi, S., Gibson, B. N., Koh, H. J. W., Gašević, D., Hamblin, P. S., Trin, C., Cataldo-Miranda, P., Zomer, E., Russell, A. W., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70401
Metadata
- Authors
- Holmes-Truscott, E., Baptista, S., Ling, M., Collins, E., Ekinci, E. I., Furler, J., Hagger, V., Manski-Nankervis, J.-A., Wells, C., & Speight, J.
- Affiliations
- Deakin University (AU)
- Diabetes Victoria (AU)
- The University of Melbourne (AU)
- ORCID
- Venue
- Frontiers in Clinical Diabetes and Healthcare
- Publisher
- Frontiers Media SA
- Published
- 2023-04-20
- Volume
- 4
- Pages
- 1177030-1177030
- ISSN
- 2673-6616 (ISSN-L)
- PMC
- PMC10157033
- OpenAlex
- W4366584829
- Cited by
- 17
- References
- 70
- Citations by year
- 2026: 12 · 2025: 4 · 2024: 1
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Clinical Diabetes and Healthcare (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Diabetes Victoria
- Deakin University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, non-insulin-treated diabetes, glycemic control, HbA1c, diabetes self-efficacy, treatment modification, psychosocial outcomes, behavioral effects, moderating effect, adults with diabetes, diabetes self-management education, diabetes self-management support
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.